OrganiGram Holdings is a producer and distributor of medical and recreational cannabis based in Canada. The company specializes in high-quality, indoor-grown cannabis, catering to both patients and adult recreational consumers. OrganiGram has developed a diverse portfolio of adult-use recreational cannabis brands, including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, the company has expanded its brand offerings with the addition of Tremblant Cannabis and the artisanal craft brand Laurentian. In addition to serving the domestic market, OrganiGram is focused on establishing international business partnerships to enhance its global presence.
Motif Labs Ltd. is a cannabis and hemp extraction company based in London, Canada, established in 2017. The company specializes in manufacturing and supplying cannabis products, offering a range of services including toll processing, formulation development, and white labeling. Motif Labs assists businesses in converting biomass into concentrates and provides customized solutions for hardware and packaging, enabling clients to realize the potential of their cannabis products. Additionally, the company focuses on brand fulfillment, ensuring that their partners receive comprehensive support throughout the production process.
Phylos
Convertible Note in 2024
Phylos is a crop science company focused on the advancement of hemp and cannabis through molecular genetics and computational biology. Founded in 2014 and headquartered in Portland, Oregon, Phylos conducts genomic research to develop diverse traits in cannabis, providing growers with pure, uniform, and vigorous seeds and clones. The company offers a range of tools and services designed to assist cannabis growers in understanding their genetic options, evaluating new varieties, and fostering business growth. By integrating modern scientific techniques, Phylos aims to enhance the next generation of hemp and cannabis cultivation.
Sanity Group
Convertible Note in 2024
Sanity Group is a European cannabis company established in 2018 and headquartered in Berlin, Germany. The company is dedicated to enhancing people's quality of life through cannabinoids, focusing on health, well-being, and scientific research. Sanity Group develops consumer products derived from non-psychoactive cannabinoids, aiming to provide pharmacies and clinical institutions with access to medicinal cannabis solutions.
Sanity Group
Secondary Market in 2024
Sanity Group is a European cannabis company established in 2018 and headquartered in Berlin, Germany. The company is dedicated to enhancing people's quality of life through cannabinoids, focusing on health, well-being, and scientific research. Sanity Group develops consumer products derived from non-psychoactive cannabinoids, aiming to provide pharmacies and clinical institutions with access to medicinal cannabis solutions.
Open Book Extracts
Convertible Note in 2024
Open Book Extracts is a cGMP certified, vertically integrated grower, processor, and manufacturer of premium plant-based products, focusing on cannabinoid extracts. With a state-of-the-art extraction facility near North Carolina's Research Triangle, the company maintains control over its entire supply chain, allowing for high-quality production and innovative refinement techniques. Open Book Extracts boasts a diverse portfolio of cannabinoid isolates, including CBD, CBG, CBN, CBC, and THCV, all exceeding 99% purity. Its expert team includes Ph.D. chemists and seasoned professionals, ensuring high standards in product development and quality control. The company provides a range of services, including white labeling, private labeling, and contract manufacturing, enabling businesses to customize products according to their brand needs. Additionally, Open Book Extracts has a branch in Hong Kong, offering strategic guidance and support for clients in Asia, further expanding its global reach.
Phylos
Convertible Note in 2023
Phylos is a crop science company focused on the advancement of hemp and cannabis through molecular genetics and computational biology. Founded in 2014 and headquartered in Portland, Oregon, Phylos conducts genomic research to develop diverse traits in cannabis, providing growers with pure, uniform, and vigorous seeds and clones. The company offers a range of tools and services designed to assist cannabis growers in understanding their genetic options, evaluating new varieties, and fostering business growth. By integrating modern scientific techniques, Phylos aims to enhance the next generation of hemp and cannabis cultivation.
Phylos
Convertible Note in 2023
Phylos is a crop science company focused on the advancement of hemp and cannabis through molecular genetics and computational biology. Founded in 2014 and headquartered in Portland, Oregon, Phylos conducts genomic research to develop diverse traits in cannabis, providing growers with pure, uniform, and vigorous seeds and clones. The company offers a range of tools and services designed to assist cannabis growers in understanding their genetic options, evaluating new varieties, and fostering business growth. By integrating modern scientific techniques, Phylos aims to enhance the next generation of hemp and cannabis cultivation.
Green Tank Technologies
Series B in 2023
Green Tank Technologies Corp. designs, develops, and manufactures vaporization hardware products specifically for the cannabis industry. Established in 2015 and based in Toronto, Canada, the company offers a range of vaporization devices, including the GT M7, GT Spectrum, Core Pod System, GT Elite, GT Commuter, GT Falcon, GT Evolution, and Torrch. Green Tank is recognized as a global leader in vaporizing hardware, focusing on innovative technologies that enhance user experience and preserve the quality of cannabis extracts. The company employs True-Taste Ceramic Core Technology to ensure full flavor and optimal terpene profiles in its products, affirming its commitment to delivering high-quality devices that meet the needs of producers and extractors.
Hyasynth
Debt Financing in 2021
Hyasynth is a bioengineering company focused on producing cannabinoid products through precision fermentation, significantly reducing the environmental impact associated with the traditional cultivation of plants. By employing a scalable and cost-efficient fermentation process, Hyasynth eliminates over 97% of the carbon footprint typically associated with the CBD market, which is valued at $12 billion globally. Their innovative approach combines traditional and modern biological techniques with computational insights to develop organisms designed to address various health issues, such as multiple sclerosis, epilepsy, and Alzheimer's disease. This technology allows for the creation of regulatory-compliant products aimed at improving patient health without the need for plant cultivation.
Edibles & Infusions is a cannabis processor and soft chew manufacturer.
Hyasynth
Corporate Round in 2020
Hyasynth is a bioengineering company focused on producing cannabinoid products through precision fermentation, significantly reducing the environmental impact associated with the traditional cultivation of plants. By employing a scalable and cost-efficient fermentation process, Hyasynth eliminates over 97% of the carbon footprint typically associated with the CBD market, which is valued at $12 billion globally. Their innovative approach combines traditional and modern biological techniques with computational insights to develop organisms designed to address various health issues, such as multiple sclerosis, epilepsy, and Alzheimer's disease. This technology allows for the creation of regulatory-compliant products aimed at improving patient health without the need for plant cultivation.
Hyasynth
Corporate Round in 2018
Hyasynth is a bioengineering company focused on producing cannabinoid products through precision fermentation, significantly reducing the environmental impact associated with the traditional cultivation of plants. By employing a scalable and cost-efficient fermentation process, Hyasynth eliminates over 97% of the carbon footprint typically associated with the CBD market, which is valued at $12 billion globally. Their innovative approach combines traditional and modern biological techniques with computational insights to develop organisms designed to address various health issues, such as multiple sclerosis, epilepsy, and Alzheimer's disease. This technology allows for the creation of regulatory-compliant products aimed at improving patient health without the need for plant cultivation.
Trauma Healing Centers
Acquisition in 2017
Trauma Healing Centers Incorporated is a healthcare provider based in Dartmouth, Canada, specializing in the treatment of trauma, chronic pain, and disabling illnesses. Established in 2014, the organization employs a multidisciplinary approach to deliver a range of services, including post-traumatic stress disorder (PTSD) treatment, trauma therapy, and chronic pain management, supported by a team of physicians, psychologists, massage therapists, and dieticians. In addition to traditional therapies, the centers offer alternative medicine and nutrition counseling. They also provide consultations on medical cannabis and sell related accessories through an online store. Trauma Healing Centers serve Canadian veterans, first responders, citizens, and their families, with locations in Halifax, Dartmouth, Moncton, Fredericton, and Ottawa. The organization operates as a subsidiary of Harvest Medicine Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.